Articles & Blogs Brexit Pharma & Life Sciences
Friday, 13 January 2017
Pfizer is shutting two manufacturing plants in the UK. One site to close within the next few months is at Park Royal in London, which Pfizer recently took over from Hospira.
Articles & Blogs Pharma & Life Sciences
Congratulations to Bernadette Brown, whose Cadham Pharmacy has been named as Pharmacy Practice of the Year at the Scottish Pharmacist Awards 2016.
Thursday, 12 January 2017
In order for there to be a binding agreement, there needs to be acceptance by one party of an offer made by another. Failure to agree on all points would mean that there is no binding agreement.
In the pharmaceutical repackaging case of Ferring Laegemidler A/S v Orifarm A/S, the Court of Justice of the European Union (the CJEU) has given its decision
Small businesses are being encouraged to give their input into a new process that is designed to speed up payments to them.
The election of Donald Trump as President Elect has created a ripple effect of disruption across the globe in many areas of business - the pharma sector being no different.
A hard Brexit could lead to more expensive drugs as well as an increased number of shortages.
Tuesday, 08 November 2016
Up to £2 billion is wasted each year by the National Health Service on ineffective treatments, claims the Academy of Medical Royal Colleges.
Cancer Research UK, the Wellcome Trust, Syncona and BACIT have announced plans to create an up to £1 billion company to invest in life sciences.
The National Pharmacy Association (NPA) has launched a legal challenge against the Government's proposed plans to cut £113 million from the pharmacy budget.
The General Medical Council has launched an investigation after a number of antibiotics were prescribed freely by some online pharmacies in ways that should not have happened according to NICE guidelines.
Wednesday, 26 October 2016
The Accelerated Access Review (AAR), originally commissioned by the Government in November 2014, has published its final report.
Tuesday, 25 October 2016
The pharmaceutical industry in the European Union is losing €10.2bn a year, or 4.4% of sales, due to counterfeit medicines.
A baby boy which has genetic material from three adults has been born.
The Government has announced that community pharmacy funding will be cut by 4% for 2016-2017 and 3.4% for 2017-2018 - an overall reduction in funding to approximately £2.592bn.